Cargando…
Design and synthesis of tag-free photoprobes for the identification of the molecular target for CCG-1423, a novel inhibitor of the Rho/MKL1/SRF signaling pathway
CCG-1423 and related analogues represent a new class of inhibitors of Rho/MKL1/SRF-mediated gene transcription, a pathway that has been implicated in both cancer and fibrosis. The molecular target for these compounds is unknown. To facilitate its identification, a series of tag-free photoaffinity pr...
Autores principales: | Bell, Jessica L, Haak, Andrew J, Wade, Susan M, Sun, Yihan, Neubig, Richard R, Larsen, Scott D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Beilstein-Institut
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3678708/ https://www.ncbi.nlm.nih.gov/pubmed/23766813 http://dx.doi.org/10.3762/bjoc.9.111 |
Ejemplares similares
-
RPEL Proteins Are the Molecular Targets for CCG-1423, an Inhibitor of Rho Signaling
por: Hayashi, Ken’ichiro, et al.
Publicado: (2014) -
Small-Molecule Inhibition of Rho/MKL/SRF Transcription in Prostate Cancer Cells: Modulation of Cell Cycle, ER Stress, and Metastasis Gene Networks
por: Evelyn, Chris R., et al.
Publicado: (2016) -
A Study of C2C12 Myoblast Bioenergetics in Response to the CCG-1423 Rho A Inhibitor
por: Nguyen, Bachkhoa, et al.
Publicado: (2021) -
Stereospecific Inhibitory Effects of CCG-1423 on the Cellular Events Mediated by Myocardin-Related Transcription Factor A
por: Watanabe, Bunta, et al.
Publicado: (2015) -
Synaptic localisation of SRF coactivators, MKL1 and MKL2, and their role in dendritic spine morphology
por: Kaneda, Marisa, et al.
Publicado: (2018)